Literature DB >> 8065291

Hepatitis B vaccination of adolescents--California, Louisiana, and Oregon, 1992-1994.

.   

Abstract

Although hepatitis B vaccine has been available in the United States since 1982, acute and chronic hepatitis B virus (HBV) infection remains a public health problem. The comprehensive national strategy to prevent HBV transmission includes hepatitis B vaccination of adolescents, particularly in communities with high rates of injecting-drug use, teenage pregnancy, and/or sexually transmitted diseases (STDs). However, vaccination of adolescents may be difficult because of their lack of routine health-care visits. This report describes hepatitis B vaccination programs for adolescents and preadolescents in schools and other settings in California, Louisiana, and Oregon during 1992-1994.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8065291

Source DB:  PubMed          Journal:  MMWR Morb Mortal Wkly Rep        ISSN: 0149-2195            Impact factor:   17.586


  7 in total

1.  Effectiveness and cost comparison of two strategies for hepatitis B vaccination of schoolchildren.

Authors:  Maryse Guay; Anne-Marie Clouâtre; Manon Blackburn; Geneviève Baron; Philippe De Wals; Chantale Roy; Jean Desrochers; François Milord
Journal:  Can J Public Health       Date:  2003 Jan-Feb

Review 2.  Promoting prevention of viral hepatitis in the African American community.

Authors: 
Journal:  J Natl Med Assoc       Date:  2003-04       Impact factor: 1.798

3.  Focusing on flu: adolescents' perspectives on school-located immunization programs for influenza vaccine.

Authors:  Mary B Short; Amy B Middleman
Journal:  Hum Vaccin Immunother       Date:  2013-09-09       Impact factor: 3.452

Review 4.  School-located vaccination for adolescents: Past, present, and future and implications for HPV vaccine delivery.

Authors:  Amy Middleman
Journal:  Hum Vaccin Immunother       Date:  2016-05-12       Impact factor: 3.452

5.  Substance abuse and high-risk needle-related behaviors among homeless youth in Minneapolis: implications for prevention.

Authors:  A R Lifson; L L Halcón
Journal:  J Urban Health       Date:  2001-12       Impact factor: 3.671

6.  Mothers' support for voluntary provision of HPV vaccine in schools.

Authors:  Jessica A Kadis; Annie-Laurie McRee; Sami L Gottlieb; Morgan R Lee; Paul L Reiter; Patricia J Dittus; Noel T Brewer
Journal:  Vaccine       Date:  2011-02-05       Impact factor: 3.641

7.  Cost-effectiveness of a potential vaccine for human papillomavirus.

Authors:  Gillian D Sanders; Al V Taira
Journal:  Emerg Infect Dis       Date:  2003-01       Impact factor: 6.883

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.